LOINCActive

LOINC Code 62805-7: PhenX - fasting serum insulin protocol 141301

62805-7 is a LOINC code used to identify PhenX - fasting serum insulin protocol 141301 in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - fasting serum insulin protocol 141301. It is commonly used with the system or sample type ^Patient.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - fasting serum insulin protocol 141301. It is commonly used with the system or sample type ^Patient.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Panel type: Panel
  • Method: PhenX

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • PhenX - fasting serum insulin protocol 141301
  • This protocol provides instructions for drawing, processing and storing blood according to the National Health and Nutrition Examination Survey (NHANES) methods. As there are no standard assays for insulin, the protocol also provides basic guidelines to aid comparability among different studies. Although all three are valuable standalone measures and all should be collected if resources are available, the Diabetes Working Group recommends that investigators prioritize Insulin 1st, C-peptide 2nd and Proinsulin 3rd. This is because results from the Insulin bioassay can be combined with results from Fasting Plasma Glucose bioassay to derive the homeostatic model assessment (HOMA) of insulin resistance and pancreatic beta cell function. The Diabetes Working Group notes that while it is not the preferred method, the Serum Insulin Assay can be performed on individuals who have not met the fasting requirements. The Diabetes Working Group notes that there are also protocols to collect samples for Serum Insulin concentrations at 0, 30, 60, 90 and 120 minutes and that this could be done at the same time as the Oral Glucose Tolerance Test. Such protocols would give extra specificity and information but would increase the burden on both the participant and investigator.
  • HUM; Humulin; IH7; Insul; Lente; NPH; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Semilente; Ser; Sliding; SR; Ultralente

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

PhenX - fasting serum insulin protocol 141301Fasting serum insulin protoPANEL.PHENX-Pt^PatientPhenX

Frequently asked questions

Code details

Code62805-7
SystemLOINC
Display namePhenX - fasting serum insulin protocol 141301
Short nameFasting serum insulin proto
ComponentPhenX - fasting serum insulin protocol 141301
Property-
TimingPt
System (specimen)^Patient
Scale-
MethodPhenX
ClassPANEL.PHENX
StatusACTIVE

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.36
Last changed2.81

Part names

PhenX - fasting serum insulin protocol 141301-Pt^PatientPhenXPoint in time (spot)

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.

LOINC Code 62805-7 | HealthAssure